Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant therapy for colon cancer.

A J Schutt1

  • 1Mayo Clinic, Rochester, Minnesota, USA.

Contemporary Internal Medicine
|January 8, 1995
PubMed
Summary

Adjuvant therapy after surgery offers clear benefits for stage III colon cancer patients. For stage II colon cancer, treatment decisions should be individualized based on patient factors.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.

Cancer·2001
Same author

PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma.

Investigational new drugs·1999
Same author

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.

International journal of radiation oncology, biology, physics·1998
Same author

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma.

Cancer·1996
Same author

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo Clinic.

Cancer·1995
Same author

Advanced colorectal adenocarcinoma: treatment with amonafide.

Journal of the National Cancer Institute·1994

Area of Science:

  • Oncology
  • Gastrointestinal Surgery

Background:

  • Adjuvant therapy is crucial in managing colon cancer post-surgery.
  • Accurate staging is essential for determining appropriate treatment strategies.

Purpose of the Study:

  • To evaluate the benefits of adjuvant therapy in colon cancer.
  • To provide guidance on treatment decisions for different stages of colon cancer.

Main Methods:

  • Review of controlled studies on adjuvant therapy efficacy.
  • Analysis of treatment outcomes based on colon cancer stage.

Main Results:

  • Definite benefits observed with adjuvant therapy for stage III colon cancer.
  • Individualized assessment recommended for stage II colon cancer treatment.

Conclusions:

  • Adjuvant therapy is a proven benefit for stage III colon cancer.
  • Personalized treatment plans are necessary for stage II colon cancer management.